Posts by Magali Bischof

GlaxoSmithKline‘s President, Philip Hampton,  has announced his departure a month after the British pharmaceutical group unveiled its plan to create a joint venture with Pfizer to become a leader in non-prescription drugs.   Read AGEFI’s full article in French Read the Financial Times full article in English

Eleven startups from EPFL were present @ CES19 this January. The event was a chance for them to showcase their products. Swiss innovation made a great hit thanks to these impressive projects.   Read the full EPFL article in English here.

Researchers at EPFL have discovered that chemotherapy-treated mammary tumors create small vesicles that help them reach new organs. Read the full EPFL article in English here

What a year for EPFL startups with a total amount raised of CHF 217 million in 2018! The investment was made across different technology sectors, with biotech and medtech strongly represented. Abionic is one of the top startups by bringing CHF 20 million to the final amount.   Read the full EPFL article here and…

GSK and Pfizer are joining forces to become a worldwide non-prescription drug giant.   Read AGEFI’s full article in French

UNIGE researchers have observed how the second X chromosome in women is gradually inactivated cell by cell to avoid identical genes colliding. Read the full UNIGE article in English here

The University of Geneva researchers have developed U-ExM which delicately inflate cells to facilitate an efficient imaging of cellular ultrastructures. The research paper was published in Nature methods revue.   Read more concerning this research on the UNIGE website    

What is Cybermedicine’s place in today’s society?   Professor Antoine Geissbuhler, Medical-Head of the Department of CyberHealth and Telemedicine and Director of the HUG Innovation Centre; answers Elisabeth Gordon‘s questions for the monthly HUG magazine, Pulsations.   Read the full interview in French